Sign In
Buy FLGT
$18.14
-0.560 (-2.99%)
At Close: Jun 03, 2026
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
07:00am, Friday, 27'th Feb 2026
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
07:30am, Thursday, 12'th Feb 2026
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a the
Fulgent Genetics (NASDAQ:FLGT) & PPJ Enterprise (OTCMKTS:PPJE) Head to Head Survey
01:24am, Saturday, 07'th Feb 2026
PPJ Enterprise (OTCMKTS:PPJE - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock
03:59am, Tuesday, 27'th Jan 2026
Fulgent Genetics offers a fortress balance sheet, zero debt, and net assets near the current share price, providing downside protection. FLGT's diagnostics business is growing, with 15.4% revenue grow
SG Americas Securities LLC Purchases New Position in Fulgent Genetics, Inc. $FLGT
04:56am, Sunday, 25'th Jan 2026
SG Americas Securities LLC acquired a new position in Fulgent Genetics, Inc. (NASDAQ: FLGT) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts
05:44am, Sunday, 18'th Jan 2026
Fulgent Genetics, Inc. (NASDAQ: FLGT - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. One equ
New Strong Buy Stocks for January 12th
06:55am, Monday, 12'th Jan 2026
ERO, NU, KSS, FLGT and BODI have been added to the Zacks Rank #1 (Strong Buy) List on Jan.12, 2026.
Contrasting Bullfrog AI (NASDAQ:BFRG) & Fulgent Genetics (NASDAQ:FLGT)
02:10am, Friday, 02'nd Jan 2026
Bullfrog AI (NASDAQ: BFRG - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two co
Analyzing Careview Communications (OTCMKTS:CRVW) & Fulgent Genetics (NASDAQ:FLGT)
01:46am, Thursday, 25'th Dec 2025
Careview Communications (OTCMKTS:CRVW - Get Free Report) and Fulgent Genetics (NASDAQ: FLGT - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the tw
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
01:36pm, Tuesday, 23'rd Dec 2025
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
04:10pm, Monday, 22'nd Dec 2025
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company with a well-established laboratory services business and a therapeutic development
Financial Contrast: Patient Portal Technologies (OTCMKTS:PPRG) versus Fulgent Genetics (NASDAQ:FLGT)
02:10am, Sunday, 30'th Nov 2025
Fulgent Genetics (NASDAQ: FLGT - Get Free Report) and Patient Portal Technologies (OTCMKTS:PPRG - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will c
Fulgent Genetics, Inc. (FLGT) Presents at UBS Global Healthcare Conference 2025 Transcript
09:04am, Tuesday, 11'th Nov 2025
Fulgent Genetics, Inc. ( FLGT ) UBS Global Healthcare Conference 2025 November 10, 2025 5:00 PM EST Company Participants Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer
Fulgent to Participate in Upcoming Conferences
04:05pm, Friday, 07'th Nov 2025
EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a th
Fulgent Genetics, Inc. (FLGT) Q3 2025 Earnings Call Transcript
02:56pm, Friday, 07'th Nov 2025
Fulgent Genetics, Inc. ( FLGT ) Q3 2025 Earnings Call November 7, 2025 8:30 AM EST Company Participants Ming Hsieh - Chairman & CEO Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financi
